Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new Revision: v3.6.5 label appears on the page. Several elements from the previous revision, including site listings, collaborator and sponsor details, and metadata such as dates and revision notes, have been removed or updated to reflect the new revision.
    Difference
    17%
    Check dated 2026-08-09T11:10:36.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page's revision indicator was updated to v3.6.4, signaling a minor update to the page rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T18:09:30.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Lung cancer and MedlinePlus Genetics were added under the related topics section to provide additional background links. This helps readers access background information about the condition and genetics resources.
    Difference
    0.2%
    Check dated 2026-07-18T15:50:37.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.6.2 to v3.6.3 on the page. This represents a minor page update (likely for fixes or formatting) with no apparent changes to study details.
    Difference
    0.1%
    Check dated 2026-07-04T13:30:06.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a new deployment of the Study Details page. This likely reflects minor updates or fixes to formatting or backend data without altering the displayed study information.
    Difference
    0.1%
    Check dated 2026-06-27T05:59:00.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    Recruitment status and new help sections were added, including How to Read a Study Record, Common Questions, and How to Join a Study; the Intervention/Treatment heading was added, while some related topics and the Lung Cancer label were removed, and the page was updated to revision v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-13T01:12:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.